GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Targeted Clincial Trials to Reduce the Risk of Antimocribal Resistance

$2,434,268
Keith Kaye · Wayne State University · N01 · FY2015 · AI

FMRG: Bio: Enabling Cell-Free Engineering and Biomanufacturing of Bacteriophages as a Universal Platform for Tailorable Bioactive Materials

$2,430,641
Vincent Noireaux · University Of Minnesota-Twin Cities · · FY2022 · ENG

Treatment of Infections in Immunocompromised Children

$2,414,206
Thomas J Walsh · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

$2,411,532
Cesar Augusto Arias · Methodist Hospital Research Institute · P01 · FY2022 · AI

Exploiting membrane targets to overcome antibiotic resistance

$2,410,919
Suzanne L. Walker · Harvard Medical School · U19 · FY2022 · AI

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

$2,406,527
Cesar Augusto Arias · Methodist Hospital Research Institute · P01 · FY2024 · AI

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,402,665
Robert A Britton · Baylor College Of Medicine · U19 · FY2022 · AI

Inducible epithelial antiviral resistance to prevent asthma

$2,400,000
Scott E. Evans · University Of Tx Md Anderson Can Ctr · DP2 · FY2013 · HL

Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis

$2,399,184
Jerrold J. Ellner · Rbhs-New Jersey Medical School · U19 · FY2018 · AI

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,390,117
Robert A Britton · Baylor College Of Medicine · U19 · FY2021 · AI

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

$2,378,848
Cesar Augusto Arias · University Of Texas Hlth Sci Ctr Houston · P01 · FY2021 · AI

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)

$2,377,848
Cesar Augusto Arias · Methodist Hospital Research Institute · P01 · FY2025 · AI

A common denominator of pathogenesis; a rare opportunity for novel therapeutic de

$2,377,500
Douglas Alan Mitchell · University Of Illinois At Urbana-Champaign · DP2 · FY2011 · OD

Chemical Biology of Infectious Disease

$2,364,153
Thomas Edward Prisinzano · University Of Kansas Lawrence · P20 · FY2016 · GM

Attacking failure of antibiotic treatment by targeting antimicrobial resistance enabler cell-states

$2,362,994
Tim Van Opijnen · Broad Institute, Inc. · U19 · FY2022 · AI

Harvard-wide Program on Antibiotic Resistance

$2,362,774
Michael S. Gilmore · Massachusetts Eye And Ear Infirmary · P01 · FY2022 · AI

Uncovering synergistic antibiotic cocktails with comparative genomics

$2,347,500
Erik Scott Wright · University Of Pittsburgh At Pittsburgh · DP2 · FY2018 · AI

Systems Epigenomics of Persistent Bloodstream Infection

$2,344,235
Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2024 · AI

Pharmaceutical Research Center

$2,340,738
Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD

Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is

$2,339,559
Arnold Louie · University Of Florida · P01 · FY2025 · AI

Mining Genomes for Synergistic Antibiotics

$2,332,500
Bo Li · Univ Of North Carolina Chapel Hill · DP2 · FY2017 · HD

Comprehensive Sickle Cell Center

$2,331,457
Winfred C Wang · St. Jude Children'S Research Hospital · U54 · FY2007 · HL

Systems Epigenomics of Persistent Bloodstream Infection

$2,326,682
Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2025 · AI

Systems Biology Approach to Redefine Susceptibility Testing and Treatment of MDR Pathogens in the Context of Host Immunity

$2,322,437
Bernhard O Palsson · University Of California, San Diego · U01 · FY2017 · AI

Application of Genomic Approaches to Bacterial Pathogenesis and Mechanisms of Antimicrobial Resistance

$2,313,646
John Dekker · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI